Peptide profile
PEG-MGF
PEG-MGF for muscle hyperplasia and repair
Compare PEG-MGF with other peptides →Summary
A peptide that wakes up your muscle's repair cells.
- Typical dose
- 200-400mcg 2-3x weekly
- Route
- Subcutaneous
- Cycle length
- 30-60 days
- Evidence
- Anecdotal
Mechanism
How it works
PEG-MGF acts like a muscle stem cell recruiter — it calls dormant satellite cells into action to build new muscle fibers, not just enlarge existing ones.
PEGylated analog of Mechano Growth Factor (IGF-1 splice variant) that activates muscle satellite cells and promotes proliferation of myoblasts.
Reported in research
Benefits
- Wakes up sleeping muscle helper cells
- Helps your body make brand new muscle fibers
- Helps you heal faster after getting hurt
- Built to last longer inside your body
Context, not a prescription
Dosing
- Typical range
- 200-400mcg 2-3x weekly (Subcutaneous)
- Cycle length
- 30-60 days
Safety
Side effects & contraindications
Possible side effects
- Injection site pain
- Localized swelling
- Mild fatigue
- Headache
- Nausea
- Dizziness
Contraindications
- Active cancer (theoretical risk due to IGF-1 pathway)
- Pregnancy or breastfeeding
- Known hypersensitivity
Research information, not medical advice. Always consult a licensed clinician before considering any peptide.
In depth
Full profile
What it does
You may grow new muscle fibers, heal faster, and recover better.
How it works
PEG-MGF is like a coach for muscle helper cells. It calls sleeping cells to wake up. They build brand new muscle, not just bigger muscle.
It sticks to special spots on your muscle helper cells. This tells them to make new cells and grow.
What to expect
Helper cells wake up in a few days. But you need several rounds to see real changes.
- Weeks 1-2: Muscle helper cells wake up.
- Weeks 3-4: You heal and recover better.
- Weeks 6-8: Your body may make new muscle fibers.
Good to know
- Use only for short times (4-8 weeks)
- Inject near the muscle you want to help
- Don't use big doses all over your body
Staying safe
- Sore spot where you got the shot
- Puffy swelling in one spot
- Feeling a little tired
Avoid if you have:
- People with cancer (it might be risky)
- People who are pregnant or breastfeeding
- People who are allergic to it
Mechanism of action
PEGylated analog of Mechano Growth Factor (IGF-1 splice variant) that activates muscle satellite cells and promotes proliferation of myoblasts.
Binds to IGF-1 receptors on muscle satellite cells, triggering proliferation and differentiation.
Pharmacodynamics
Satellite cell activation within days; visible changes require multiple cycles.
Potential muscle hyperplasia (new fibers), accelerated injury repair, enhanced recovery.
Timeline
- Weeks 1-2: Satellite cell activation.
- Weeks 3-4: Enhanced recovery and repair.
- Weeks 6-8: Potential new muscle fiber formation.
Comparisons
- PEG-MGF — effectiveness Emerging, safety Emerging, cost $$, Medium to use
- IGF-1 LR3 — effectiveness Moderate, safety Emerging, cost $$, Medium to use
Adverse effects
Common:
- Injection site pain
- Localized swelling
- Mild fatigue
Rare:
- Headache
- Nausea
- Dizziness
Contraindications & risk mitigation
Contraindicated in:
- Active cancer (theoretical risk due to IGF-1 pathway)
- Pregnancy or breastfeeding
- Known hypersensitivity
- Short cycles only (4-8 weeks)
- Local injection near target muscle
- Avoid systemic high doses
Qué hace
Puedes desarrollar nuevas fibras musculares, sanar más rápido y recuperarte mejor.
Cómo funciona
El PEG-MGF es como un entrenador para las células auxiliares del músculo. Llama a las células inactivas para que despierten. Construyen músculo completamente nuevo, no solo músculo más grande.
Se une a puntos especiales en tus células auxiliares del músculo. Esto les indica que produzcan nuevas células y crezcan.
Qué esperar
Las células auxiliares despiertan en unos días. Pero necesitas varios ciclos para ver cambios reales.
- Semanas 1-2: Las células auxiliares del músculo despiertan.
- Semanas 3-4: Te recuperas y sanas mejor.
- Semanas 6-8: Tu cuerpo puede generar nuevas fibras musculares.
Bueno saber
- Usar solo por períodos cortos (4-8 semanas)
- Inyectar cerca del músculo que deseas ayudar
- No usar dosis altas en todo el cuerpo
Manteniéndose seguro
- Zona dolorida donde te aplicaste la inyección
- Hinchazón en una zona específica
- Sentirse un poco cansado
Evitar si tienes:
- Personas con cáncer (podría ser riesgoso)
- Personas que están embarazadas o en periodo de lactancia
- Personas que sean alérgicas a este péptido
Mecanismo de acción
Análogo PEGilado del Factor de Crecimiento Mecano (variante de empalme del IGF-1) que activa las células satélite musculares y promueve la proliferación de mioblastos.
Se une a los receptores del IGF-1 en las células satélite musculares, desencadenando proliferación y diferenciación.
Farmacodinamia
Activación de las células satélite en unos días; los cambios visibles requieren múltiples ciclos.
Posible hiperplasia muscular (nuevas fibras), reparación acelerada de lesiones, recuperación mejorada.
Cronología
- Semanas 1-2: Activación de las células satélite.
- Semanas 3-4: Recuperación y reparación mejoradas.
- Semanas 6-8: Posible formación de nuevas fibras musculares.
Comparaciones
- PEG-MGF — efectividad Emergente, seguridad Emergente, costo $$, Media de usar
- IGF-1 LR3 — efectividad Moderada, seguridad Emergente, costo $$, Media de usar
Efectos adversos
Comunes:
- Dolor en el sitio de inyección
- Hinchazón localizada
- Fatiga leve
Raros:
- Dolor de cabeza
- Náuseas
- Mareos
Contraindicaciones y mitigación de riesgos
Contraindicado en:
- Cáncer activo (riesgo teórico debido a la vía del IGF-1)
- Embarazo o lactancia
- Hipersensibilidad conocida
- Solo ciclos cortos (4-8 semanas)
- Inyección local cerca del músculo objetivo
- Evitar dosis sistémicas altas
Reference data
Specifications
- Route
- Subcutaneous
- Cycle length
- 30-60 days
FAQ
Common questions
Does PEG-MGF cause cancer?
Theoretical risk exists due to IGF-1 pathway activation, but no direct evidence in humans. Avoid with active cancer.
Should PEG-MGF be stacked with IGF-1 LR3?
Yes, common protocol: PEG-MGF for proliferation, then IGF-1 LR3 for differentiation of new cells.
What is the evidence level?
This compound is classified as Anecdotal. Evidence relies primarily on self-reported user experiences. Controlled studies are lacking.
Research
Research & sources
Current evidence for PEG-MGF is rated as Anecdotal. No controlled clinical research is available.
- 1. MGF and satellite cells (2006) — DOI:10.1113/jphysiol.2006.107037
- 2. PEG-MGF in muscle repair (2010) — DOI:10.1152/japplphysiol.00086.2010
- 3. MGF and satellite cells (2006)
- 4. PEG-MGF in muscle repair (2010)